|
Lymphoma Cutaneous T Cell Cure - Lymphoma Cutaneous T Cell Medicine Drug
TREATMENT CENTERS - SURVIVAL RATE - DRUGS AND MEDICINE - INFORMATION
- ATTORNEYS


Cutaneous T cell lymphoma
From Wikipedia, the free encyclopedia
(Redirected from Cutaneous T-Cell Lymphoma)
Jump to: navigation, search
Cutaneous T cell lymphoma
Classification & external resources
ICD-10 C84.0, C84.1
ICD-9 202.1, 202.2
ICD-O: M9700/3, M9701/3
DiseasesDB 8595
eMedicine med/3486
MeSH D016410
Cutaneous T-Cell lymphoma (CTCL) is a class of non-Hodgkin's
lymphoma, which is a type of cancer of the immune system. Unlike most
non-Hodgkin's lymphomas (which are generally B-cell related), CTCL is
caused by a mutation of T cells. The malignant T cells in the body
are pushed to the surface of the skin in a biological process used to
rid the body of offending material, causing various lesions to appear
on the skin. These lesions change shape as the disease progresses,
typically beginning as what appears to be a rash and eventually
forming plaques and tumors before metastatizing to other parts of the body.
Contents [hide]
1 Types
2 Treatment
3 See also
4 External links
[edit] Types
Though there are many types of CTCL and presentation can vary from
individual to individual, there are two main forms:
mycosis fungoides (MF)
Sézary syndrome (SS)
There is some dispute over whether SS is an advanced form of MF or a
different type of CTCL entirely - in either case, the prognosis for
SS patients is substantially poorer than for those of MF.
[edit] Treatment
There is no cure for CTCL, but there are a variety of treatment
options available and some CTCL patients are able to live somewhat
normal lives with this cancer, although symptoms can be debilitating
and painful, even in earlier stages.
Treatments include: Topical Corticosteroids, Bexarotene Gel,
Carmustine(Nitrogen Mustard), Mechlorethamine, Phototherapy (Broad
& Narrow Band UVB or PUVA), Local & Total Skin Electron Beam
Radiation, Conventional Radiation Therapy, Oral Corticosteroids,
Bexarotene (Targretin®) Capsules, Photopheresis, Interferons,
Denileukin Diftitox (Ontak®), Alemtuzumab (Campath-1H),
Vorinostat (Zolinza®), Methotrexate, Pentostatin & other
purine analogues (Fludarabine, 2- deoxychloroadenosine), Liposomal
doxorubicin (Doxil®), Gemcitabine (Gemzar®),
Cyclophosphamide, oral, Bone marrow/Stem cell, and Allogenic Transplantation.
[edit] See also
Anaplastic large cell lymphoma
[edit] External links
Cutaneous T-Cell Lymphomas - The lymphoma Information Network
The Cutaneous Lymphoma Foundation
DermNet dermal-infiltrative/cutaneous-t-cell-lymphoma
Lymphoma Research Foundation
Cutaneous T-cell Lymphoma - H. Lee Moffitt Cancer Center &
Research Institute
UUHSC
NCI Clinical Trial using Depsipeptide to treat CTCL
|